0.73
0.73 (0%)
As of Apr 17, 2025
IRONWOOD PHARMACEUTICALS INC [IRWD]
Source:
Company Overview
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases.
| Country | United States |
| Headquarters | boston, massachusetts |
| Phone Number | 617-621-7722 |
| Industry | manufacturing |
| CEO | Ironwood Pharmaceuticals Inc |
| Website | www.ironwoodpharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $351.4 |
| Operating Profit | $93.1 |
| Net Income | $0.9 |
| Net Cash | $-3.6 |
Profit Ratios
| Gross Margin | $351.4 |
| Operating Margin | 26.5 |
| Profit as % of Revenues | 39,933% |
| Profit as % of Assets | 0.2% |
| Profit as % of Stockholder Equity | -0.3% |
Management Effectiveness
| Return on Equity | -0.3% |
| Return on Assets | 0.3% |
| Turnover Ratio | 85.5% |
| EBITA | $93.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $350.9 |
| Total Liabilities | $652.2 |
| Operating Cash Flow | $103.5 |
| Investing Cash Flow | $-0.1 |
| Financing Cash Flow | $-107 |
